These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serum and dialysate concentrations of cephalexin following repeated dosing in CAPD patients. Davis GM; Forland SC; Cutler RE Am J Kidney Dis; 1985 Sep; 6(3):177-80. PubMed ID: 4036960 [TBL] [Abstract][Full Text] [Related]
3. Ciprofloxacin in the treatment of gram-positive bacterial peritonitis in patients undergoing CAPD. Pérez-Fontán M; Rosales M; Fernández F; Moncalián J; Fernández-Rivera C; Alonso A; Valdés F Perit Dial Int; 1991; 11(3):233-6. PubMed ID: 1912018 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of single daily intraperitoneal administration of aztreonam and cefuroxime in the treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD). Fuiano G; Sepe V; Viscione M; Nani E; Conte G Perit Dial Int; 1989; 9(4):273-5. PubMed ID: 2488380 [TBL] [Abstract][Full Text] [Related]
7. Cefoperazone in the treatment of peritonitis in continuous ambulatory peritoneal dialysis patients. Leehey DJ; Reid R; Chan AY; Ing TS Artif Organs; 1988 Dec; 12(6):482-3. PubMed ID: 3214327 [TBL] [Abstract][Full Text] [Related]
8. Peritonitis in patients on continuous ambulatory peritoneal dialysis. A changing scene. Grefberg N; Danielson BG; Nilsson P Scand J Infect Dis; 1984; 16(2):187-94. PubMed ID: 6740249 [TBL] [Abstract][Full Text] [Related]
9. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis. Mars RL; Moles K; Pope K; Hargrove P Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311 [TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal vancomycin and ceftazidime in the treatment of CAPD peritonitis. Gray HH; Goulding S; Eykyn SJ Clin Nephrol; 1985 Feb; 23(2):81-4. PubMed ID: 3886227 [TBL] [Abstract][Full Text] [Related]
15. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis. Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719 [TBL] [Abstract][Full Text] [Related]
17. Flucytosine-miconazole treatment of Candida peritonitis. Its use during continuous ambulatory peritoneal dialysis. Lempert KD; Jones JM Arch Intern Med; 1982 Mar; 142(3):577-8. PubMed ID: 7065793 [TBL] [Abstract][Full Text] [Related]
18. Vancomycin therapy for gram-positive peritonitis in patients on CAPD. Vargemezis V; Pasadakis P; Thodis H; Coucudis P; Peihaberis P; Jafer H; Jara F; Kartali S Adv Perit Dial; 1989; 5():128-9. PubMed ID: 2577394 [TBL] [Abstract][Full Text] [Related]
19. Increased risk of Staphylococcus epidermidis peritonitis in patients on dialysate containing 1.25 mmol/L calcium. Piraino B; Bernardini J; Holley JL; Perlmutter JA Am J Kidney Dis; 1992 Apr; 19(4):371-4. PubMed ID: 1562027 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients. Tosukhowong T; Eiam-Ong S; Thamutok K; Wittayalertpanya S; Na Ayudhya DP Perit Dial Int; 2001; 21(6):587-94. PubMed ID: 11783768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]